NEDD8 protein is involved in ubiquitinated inclusion bodies

Journal of Pathology

Volumn 199, Issue 2, 2003, Pages 259-266

  Dil Kuazi, Afroz ^a   Kito, Katsumi ^a   Abe, Yasuhito ^a   Shin, Ryong Woon ^b   Kamitani, Tetsu ^c   Ueda, Norifumi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Inclusion bodies; Lewy body; Mallory body; NEDD8; Neurofibrillary tangle; Rosenthal fibre; Senile plaque; Ubiquitin

Indexed keywords

AMINO ACID; NEDD8 PROTEIN; PROTEASOME; PROTEIN ANTIBODY; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BIOACCUMULATION; CELL INCLUSION; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALLORY BODY; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SENILE PLAQUE; SEQUENCE HOMOLOGY; STEM CELL; TISSUE DISTRIBUTION;

ALZHEIMER DISEASE; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; LIVER DISEASES, ALCOHOLIC; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; RECOMBINANT PROTEINS; UBIQUITIN; UBIQUITINS;

EID: 0037312293     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1283     Document Type: Article

References (43)

1. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67: 425-479.
2. Lowe J, Mayer J, Landon M, et al. Ubiquitin and the molecular pathology of neurodegenerative diseases. Adv Exp Med Biol 2001; 487: 169-186.
3. Mori H, Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987; 235: 1641-1644.
4. Lowe J, Blanchard A, Morrell K, et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988; 155: 9-15.
5. Leigh PN, Whitwell H, Garofalo O, et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 1991; 114: 775-788.
6. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-760.
7. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
8. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
9. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395: 451-452.
10. Kumar S, Yoshida Y, Noda M. Cloning of a cDNA which encodes a novel ubiquitin-like protein. Biochem Biophys Res Commun 1993; 195: 393-399.
11. Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 1992; 267: 7806-7813.
12. Okura T, Gong L, Kamitani T, et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 1996; 157: 4277-4281.
13. Mahajan R, Delphin C, Guan T, et al. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997; 88: 97-107.
14. Kamitani T, Kito K, Nguyen HP, et al. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem 1997; 272: 28 557-28 562.
15. Kamitani T, Kito K, Nguyen HP, et al. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem 1998; 273: 11 349-11 353.
16. Whitby FG, Xia G, Pickart CM, et al. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem 1998; 273: 34 983-34R 991.
17. Osaka F, Kawasaki H, Aida N, et al. A new NEDD8-ligating system for cullin-4A. Genes Dev 1998; 12: 2263-2268.
18. Wada H, Yeh ET, Kamitani T. Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun 1999; 257: 100-105.
19. Tsvetkov LM, Yeh KH, Lee SJ, et al. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9: 661-664.
20. Spencer E, Jiang J, Chen ZJ. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev 1999; 13: 284-294.
21. Latres E, Chiaur DS, Pagano M. The human F box protein beta-Trcp associates with the Cull/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999; 18: 849-854.
22. Maxwell PH, Wiesener MS, Chang GW, et al. The turnout suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275.
23. Yu ZK, Gervais JL, Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A 1998; 95: 11 324-11 329.
24. Podust VN, Brownell JE, Gladysheva TB, et al. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci U S A 2000; 97: 4579-4584.
25. Read MA, Brownell JE, Gladysheva TB, et al. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol 2000; 20: 2326-2333.
26. Kawakami T, Chiba T, Suzuki T, et al. NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J 2001; 20: 4003-4012.
27. Lowe J, McDermott H, Loeb K, et al. Immunohistochemical localization of ubiquitin cross-reactive protein in human tissues. J Pathol 1995; 177: 163-169.
28. Wada H, Kito K, Caskey LS, et al. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem Biophys Res Commun 1998; 251: 688-692.
29. Mayer RJ, Lowe J, Landon M, et al. Ubiquitin and the lysosome system: molecular immunopathology reveals the connection. Biomed Biochim Acta 1991; 50: 333-341.
30. Manetto V, Abdul-Karim FW, Perry G, et al. Selective presence of ubiquitin in intracellular inclusions. Am J Pathol 1989; 134: 505-513.
31. Ohta M, Marceau N, Perry G, et al. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988; 59: 848-856.
32. Furukawa M, Zhang Y, McCarville J, et al. The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1 Mol Cell Biol 2000; 20: 8185-8197.
33. van Leeuwen FW, de Kleijn DP, van den Hurk HH, et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998; 279: 242-247.
34. Lowe J, McDermott H, Landon M, et al. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 1990; 161: 153-160.
35. Lowe J, McDermott H, Pike I, et al. Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 1992; 166: 61-68.
36. Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001; 293: 263-269.
37. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
38. Ishikawa A, Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 1998; 245: 4-9.
39. Kwak S, Masaki T, Ishiura S, et al. Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains. Neurosci Lett 1991; 128: 21-24.
40. Gong L, Kamitani T, Millas S, et al. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem 2000; 275: 14 212-14 216.
41. Kito K, Yeh ET, Kamitani T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem 2001; 276: 20 603-20 609.
42. Kamitani T, Kito K, Fukuda-Kamitani T, et al. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 2001; 276: 46 655-46 660.
43. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001; 292: 1552-1555.